|
|
| Q
|
Cardf1
|
Cardiac cell morphology QTL 1
|
|
IDA
|
| |
4.18
|
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr13:12,448,421...47,969,993
|
|
| Q
|
Eutr1
|
Estrogen induced uterine response QTL 1
|
|
IDA
|
| |
|
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:6,922,282...81,330,203
|
|
| Q
|
Eutr2
|
Estrogen induced uterine response QTL 2
|
|
IDA
|
| 0.01 |
|
|
RGD |
PMID:16284802 |
RGD:1559291 |
NCBI chr 5:39,526,924...84,526,924
|
|
| Q
|
Gcr1
|
Gastric cancer resistance QTL 1
|
|
IDA
|
| |
2.7
|
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:103,834,277...148,834,277
|
|
| Q
|
Gcr2
|
Gastric cancer resistance QTL 2
|
|
IDA
|
| |
2.6
|
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:29,056,275...47,904,329
|
|
| Q
|
Gcs1
|
Gastric cancer susceptibility QTL1
|
|
IDA
|
| |
3.8
|
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:82,714,037...106,778,197
|
|
| Q
|
Ginf1
|
Gastrointestinal inflammation QTL 1
|
|
IDA
|
| 0.005 |
3.52
|
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:12,964,165...57,964,165
|
|
| Q
|
Ginf2
|
Gastrointestinal inflammation QTL 2
|
|
IDA
|
| 0.005 |
3.21
|
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:12,964,165...57,964,165
|
|
| Q
|
Ginf3
|
Gastrointestinal inflammation QTL 3
|
|
IDA
|
| 0.005 |
2.89
|
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:54,829,503...93,515,804
|
|
| Q
|
Mamtr2
|
Mammary tumor resistance QTL 2
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:9,623,581...54,623,581
|
|
| Q
|
Mamtr3
|
Mammary tumor resistance QTL 3
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:14522903 |
RGD:724790 |
|
|
| Q
|
Mamtr4
|
Mammary tumor resistance QTL 4
|
|
IDA
|
| 3.0E-4 |
|
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:18,227,137...63,227,137
|
|
| Q
|
Renag1
|
Renal agenesis QTL 1
|
|
IDA
|
| |
|
|
RGD |
PMID:16845468 |
RGD:1580355 |
|
|
| Q
|
Schws8
|
Schwannoma susceptibility QTL 8
|
|
IDA
|
| |
|
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:100,704,576...101,593,851
|
|
| Q
|
Schws9
|
Schwannoma susceptibility QTL 9
|
|
IDA
|
| |
|
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:101,593,607...146,593,607
|
|
| Q
|
Tcas11
|
Tongue tumor susceptibility QTL 11
|
|
IDA
|
| |
4.12
|
|
RGD |
PMID:16527513 |
RGD:1578522 |
NCBI chr 5:51,657,967...166,600,247
|
|
| Q
|
Tcas7
|
Tongue tumor susceptibility QTL 7
|
|
IDA
|
| 0.001 |
|
|
RGD |
PMID:15876484 |
RGD:1358147 |
NCBI chr19:41,722,546...74,246,245
|
|
| Q
|
Tls1
|
T-lymphoma susceptibility QTL 1
|
|
IDA
|
| 0.001 |
0.0
|
|
RGD |
PMID:10360666 |
RGD:619600 |
|
|
| Q
|
Tls2
|
T-lymphoma susceptibility QTL 2
|
|
IDA
|
| 0.001 |
0.0
|
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 7:82,111,382...132,099,989
|
|
| Q
|
Tls3
|
T-lymphoma susceptibility QTL 3
|
|
IDA
|
| 1.0E-4 |
0.0
|
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr10:27,587,226...96,099,902
|
|
| Q
|
Vetf1
|
Vascular elastic tissue fragility QTL 1
|
|
IDA
|
| 1.0E-4 |
5.0
|
|
RGD |
PMID:11526202 |
RGD:619605 |
NCBI chr 5:7,065,535...10,687,501
|
|
| Q
|
Vetf2
|
Vascular elastic tissue fragility QTL 2
|
|
IDA
|
| 2.0E-4 |
4.5
|
|
RGD |
PMID:11526202 |
RGD:619605 |
NCBI chr10:35,509,383...91,417,879
|
|